LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), announces that both the Board of Directors have approved an up to 60-for-1 reverse stock split of the Company's common stock. The reverse split is pending
-- This Extension Increases Flexibility and Efficiency for Customers and Patients --
PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing